Reuters Health News Summary

Following is a summary of current health news briefs. Factbox - Latest on the worldwide spread of the coronavirus Moderna Inc said on Monday its COVID-19 vaccine generated a strong immune response in children aged six to 11 years and that it plans to submit the data to global regulators soon.


Reuters | Updated: 26-10-2021 02:30 IST | Created: 26-10-2021 02:30 IST
Reuters Health News Summary

Following is a summary of current health news briefs.

Factbox - Latest on the worldwide spread of the coronavirus

Moderna Inc said on Monday its COVID-19 vaccine generated a strong immune response in children aged six to 11 years and that it plans to submit the data to global regulators soon. DEATHS AND INFECTIONS

Moderna says its COVID-19 vaccine protective, safe in young children

Moderna Inc said on Monday its COVID-19 vaccine generated a strong immune response in children aged six to 11 years and that it plans to submit the data to global regulators soon. Moderna said its two-dose vaccine generated virus-neutralizing antibodies in children and safety was comparable to what was previously seen in clinical trials of adolescents and adults. It cited interim data that has yet to be peer reviewed.

Bausch, Clearside receive U.S. approval for eye injection

Bausch Health Companies Inc and Clearside Biomedical Inc said on Monday they received approval from the U.S. health regulator for their eye injection, giving patients access to a novel treatment for vision loss resulting from an inflammatory eye condition. The drug, Xipere, is injected to the back of the eye and delivers a version of a steroid commonly used for the treatment of uveitis, an inflammation of tissues in the eye.

EU regulator starts real-time review of Merck's COVID-19 pill

U.S. drugmaker Merck & Co Inc said on Monday the European Union's drug regulator has initiated a real-time review of its experimental COVID-19 antiviral drug for adults. Under the procedure, also known as a "rolling review", the European Medicines Agency (EMA) would assess data as soon as it becomes available, instead of waiting for a formal application when all required information has been gathered.

Number of COVID-19 infections in Spain hits 5 million

Spain on Monday reached the grim milestone of 5 million COVID-19 cases during the pandemic, as it reported 4,485 new infections and 54 deaths since Friday. The total number of people who have now tested positive for COVID-19 is 5,002,217 according to Health Ministry data.

Flu jabs may aid COVID-19 patients who need surgery

The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that have yet to be certified by peer review. Flu-vaccinated COVID-19 patients have easier surgeries

Europe drug regulator backs use of Moderna's COVID-19 booster vaccine

The European Union's drug regulator on Monday said it has concluded in its review that Moderna's COVID-19 booster vaccine may be given to people aged 18 years and above, at least six months after the second dose. It is the second COVID-19 booster vaccine to be approved in the EU.

U.S. to invest $70 million to boost access to COVID-19 tests

The Biden administration said it will invest $70 million to boost the availability and lower costs of rapid, over-the-counter COVID-19 tests in the United States, as it looks to ease a nationwide shortage that drove up testing costs.

High demand for the tests from U.S. employers amidst the Delta variant surge, especially with the U.S. government mandating large employers to have their workers inoculated and tested weekly, pushed up costs for state and local testing programs.

Analysis: Capitol Hill drug pricing reform opponents among the biggest beneficiaries of pharma funds

Democratic Party lawmakers holding up proposed drug pricing reforms are among the largest beneficiaries of the pharmaceutical industry's push to stave off price cuts, a Reuters analysis of public lobbying and campaign data shows. The industry, which traditionally gives more to Republicans, channeled around 60% of donated campaign funds to Democrats this year. It has spent over $177 million on lobbying and campaign donations in 2021.

Russian COVID cases hit record high as eastern Europe imposes new curbs

Russia reported a record high number of daily COVID-19 cases and some central European countries imposed fresh restrictions on Monday, as a new wave of the pandemic gathered pace. In Asia, the Red Cross called for urgent help for Papua New Guinea and China's latest outbreak forced the capital Beijing to delay its annual marathon and step up other curbs, less than four months before it hosts the Winter Olympics.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Give Feedback